Author Correction: The foundations of immune checkpoint blockade and the ipilimumab approval decennial
Nat Rev Drug Discov
.
2022 Feb;21(2):163.
doi: 10.1038/s41573-022-00393-8.
Authors
Alan J Korman
1
,
Sarah C Garrett-Thomson
2
,
Nils Lonberg
3
Affiliations
1
Vir Biotechnology, San Francisco, CA, USA. akorman@vir.bio.
2
Albert Einstein College of Medicine, Bronx, NY, USA. sarah.garrett@einsteinmed.org.
3
Canaan Partners, Menlo Park, CA, USA. nlonberg@canaan.com.
PMID:
35031767
DOI:
10.1038/s41573-022-00393-8
No abstract available
Publication types
Published Erratum